Sanofi's market cap is currently ―. The company's EPS TTM is $2.334; its P/E ratio is 20.84; and it has a dividend yield of 2.78%. Sanofi is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is $0.94. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 13.14B	$ 10.74B	$ 10.05B
Gross Profit	-	-	$ 9.31B	$ 7.49B	$ 7.17B
EBIT	-	-	$ 2.78B	$ 1.46B	$ 2.41B
EBITDA	-	-	$ 3.24B	$ 1.92B	$ 2.86B
Net Income Common Stockholders	-	-	$ 2.08B	$ 1.18B	$ 2.01B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.71B	$ 677.00M	$ 0.00	$ 6.90B	$ 0.00
Total Assets	$ 126.46B	$ 113.99B	-	$ 121.83B	-
Total Debt	$ 18.15B	$ 21.21B	$ 0.00	$ 21.24B	$ 0.00
Net Debt	$ 9.44B	$ 20.54B	$ 0.00	$ 14.34B	$ 0.00
Total Liabilities	$ 52.11B	$ 51.00B	-	$ 50.52B	-
Stockholders Equity	$ 74.04B	$ 74.78B	$ 0.00	$ 70.95B	$ 0.00
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in USD

Sanofi Earnings and Revenue History

Income Statement >

Sanofi Debt to Assets

Balance Sheet >

Sanofi Cash Flow

Cash Flow >

Sanofi Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing